Combining the tumor abnormal protein test with tests for carcinoembryonic antigens, cancer antigen 15–3, and/or cancer antigen 125 significantly increased their diagnostic sensitivity for breast cancer

BACKGROUND: The tumor abnormal protein (TAP) test is used to screen for many cancers, but its use for breast cancer has not been studied. METHODS: Tests for carcinoembryonic antigen (CEA), cancer antigen 125 (CA125), cancer antigen 15-3 (CA15-3), and TAP were administered to 261 women with operable...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Rui, Jiang, Chaojun, Zhu, Qiannan, You, Sainan, Li, Yan, Li, Shuo, Ding, Lei, Meng, Haojie, Yang, Yuxin, Zha, Xiaoming, Wang, Jue
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2020
Materias:
5750
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373588/
https://www.ncbi.nlm.nih.gov/pubmed/32702897
http://dx.doi.org/10.1097/MD.0000000000021231

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7373588/
https://www.ncbi.nlm.nih.gov/pubmed/32702897
http://dx.doi.org/10.1097/MD.0000000000021231

Ejemplares similares